A Universal Gut-Microbiome-Derived Signature Predicts Cirrhosis
Tae Gyu Oh(University of Oklahoma Health Sciences Center), Rohit Loomba(University of California San Diego), Claude B. Sirlin(University of California San Diego), Cyrielle Caussy(Hospices Civils de Lyon), Jian Guo(Dalian Polytechnic University), Seema Singh(University of Mississippi Medical Center), Ruth T. Yu(Peking University), Ricki Bettencourt(University of California San Diego), Annette R. Atkins(Salk Institute for Biological Studies), Susy M. Kim(University of California San Diego), Ronald M. Evans(University of California San Diego), Michael Downes(Salk Institute for Biological Studies), Ting Fu(Chongqing University of Technology), Lisa Richards(University of California San Diego), Shirin Bassirian(University of California San Diego), Egbert Madamba(University of California San Diego), Tao Huan(University of British Columbia Hospital), David A. Brenner(Institute of Medical Microbiology and Hygiene)
Cited by 72
Related Papers
Liver fibrosis
|Journal of Clinical Investigation|2005|4.7k
Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases
|Hepatology|2018|4.7k
AASLD guidelines for the treatment of hepatocellular carcinoma
|Hepatology|2017|4.2k
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
|Hepatology|2023|2.9k
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
|Journal of Hepatology|2023|2.7k